Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Total search results: 16882 | Ordered by Date (descending)
1 2 3 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. 2018-12-18
Bruker Corporation. (12/18/18). "Press Release: Bruker Completes the Acquisition of Alicona Imaging GmbH". Billerica, MA. 2018-12-18
Selexis S.A.. (12/17/18). "Press Release: Teneobio and Selexis Enter Second Services Agreement to Develop Research Cell Banks". Geneva & Menlo Park, CA. 2018-12-17
Mobidiag Oy. (12/17/18). "Press Release: Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment". Espoo. 2018-12-17
Versant Ventures. (12/17/18). "Press Release: Versant Ventures Raises $700 Million". San Francisco, CA, New York, NY & Vancouver, BC. 2018-12-17
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Novo Nordisk A/S. (12/17/18). "Press Release: Staten Biotechnology B.V. and Novo Nordisk A/S Announce Collaboration to Develop Novel Treatment for Dyslipidaemia". Nijmegen & Copenhagen. 2018-12-17
OncoImmunity AS. (12/17/18). "Press Release: OncoImmunity Receives €2.2 Million to Roll Out Its Machine-learning Platform to Enable the Development of Personalized Cancer Immunotherapies". Oslo. 2018-12-17
Santhera Pharmaceuticals Holding AG. (12/14/18). "Press Release: Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license". Pratteln. 2018-12-14
BRAIN AG. (12/14/18). "Press Release: BRAIN Achieves Double-digit Growth in Total Operating Performance and Revenues in the 2017/18 Financial Year". Zwingenberg. 2018-12-14
Noxxon Pharma N.V.. (12/14/18). "Press Release: Noxxon Announces Key Findingsthat NOX-A12 plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients". Berlin. 2018-12-14
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. 2018-12-13
c-LEcta GmbH. (12/13/18). "Press Release: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019". 2018-12-13
Third Rock Ventures, LLC. (12/13/18). "Press Release: Third Rock Ventures Names Christoph Lengauer, Ph.D., and Jeffrey Tong, Ph.D., as Partners". Boston, MA. 2018-12-13
Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. 2018-12-13
Lead Discovery Center GmbH. (12/13/18). "Press Release: LDC and the University of Duisburg-Essen Receive EUR 905,000 for the Development of New Therapies for Age-related Blindness". Dortmund. 2018-12-13
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
AC Immune S.A.. (12/12/18). "Press Release: AC Immune and Lilly Announce License and Collaboration Agreement". Lausanne & Indianapolis, IN. 2018-12-12
Santhera Pharmaceuticals Holding AG. (12/12/18). "Press Release: Santhera Announces Financial Results for the First Nine Months of 2018". Pratteln. 2018-12-12
BRAIN AG. (12/11/18). "Press Release: Global Beverage Company Joins BRAIN’s Newly Established FRESCO Program for Nature-based Preservation Ingredients". Zwingenberg & Potsdam. 2018-12-11
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Oxford BioTherapeutics Ltd.. (12/11/18). "Press Release: Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody Platform for Five Bispecific Antibody Programs for up to $450 Million". Shanghai & Oxford. 2018-12-11
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
10x Genomics Inc.. (12/10/18). "Press Release: 10x Genomics Acquires Spatial Transcriptomics". Pleasanton, CA. 2018-12-10
Centogene AG. (12/10/18). "Press Release: Centogene and Chiesi Germany Sign Strategic Alliance in Lysosomal Storage Disorders". Rostock & Hamburg. 2018-12-10
Roche. (12/10/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2018-12-10
Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford. 2018-12-10
Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA. 2018-12-10
Lonza Group AG. (12/10/18). "Press Release: Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution". Basel & Guangzhou. 2018-12-10
AstraZeneca plc. (12/10/18). "Press Release: AstraZeneca and Cancer Research UK Launch Functional Genomics Centre to Accelerate the Discovery of New Medicines". 2018-12-10
AstraZeneca plc. (12/7/18). "Press Release: Update on the Phase III EAGLE Trial of Imfinzi and Tremelimumab in Advanced Head and Neck Cancer". 2018-12-07
AC Immune S.A.. (12/7/18). "Press Release: In Memoriam – Dr. Andreas Muhs CSO, Scientific Leader and Friend Has Passed Away". Lausanne. 2018-12-07
Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt. 2018-12-06
Novartis AG. (12/6/18). "Press Release: Novartis Investigational BYL719 (alpelisib) plus Fulvestrant Consistently Improved PFS in Patients with PIK3CA Mutated HR+/HER2- Advanced Breast Cancer in New SOLAR-1 Analyses". Basel. 2018-12-06
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
Qiagen N.V.. (12/6/18). "Press Release: Qiagen Announces New Collaboration to Develop Companion Diagnostic to Guide Treatment for Patients with PIK3CA-mutated Advanced Breast Cancer". Germantown, MD & Hilden. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
Genomics England Ltd.. (12/5/18). "Press Release: The UK Has Sequenced 100,000 Whole Genomes in the NHS. Pioneering 100,000 Genomes Project Reaches Its Goal and Thanks All Involved". 2018-12-05
Evotec AG. (12/4/18). "Press Release: Evotec and Leo Pharma Form Drug Discovery Alliance Targeting Dermatological Conditions". Hamburg & Ballerup. 2018-12-04
Alacris Theranostics GmbH. (12/4/18). "Press Release: Alacris Theranostics startet Seedmatch-Crowdfunding-Kampagne für einzigartige computergestützte Tumoranalyse zur Optimierung von Krebstherapien". 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. 2018-12-03
SpinDiag GmbH. (12/3/18). "Press Release: SpinDiag Closes Second Financing Round of EUR 3.0 million (USD 3.4 million) to Complete Product Development of Its Point-of-Care Screening System for Antibiotic-resistant Bacteria". Freiburg. 2018-12-03
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. 2018-12-03
Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen. 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK to Divest Horlicks and other Consumer Healthcare Nutrition Products to Unilever". 2018-12-03
Genedata AG. (12/3/18). "Press Release: Genedata Opens New Subsidiary in Singapore to Support Growing Business in Asia and Australia". Singapore. 2018-12-03
CMS Hasche Sigle. (12/3/18). "Press Release: CMS berät Wellington und HBM als Lead Investoren der Serie D-Finanzierungsrunde der Adrenomed". München. 2018-12-03
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia". Breda & Ghent. 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK Reaches Agreement to Acquire Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2018-12-03
Aprea AB. (12/2/18). "Press Release: Aprea Therapeutics Closes EUR 50 Million Financing". Boston, MA & Stockholm. 2018-12-02
Aprea AB. (12/2/18). "Press Release: Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual 2018-12-02
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL. 2018-11-30
MaSTherCell S.A.. (11/30/18). "Press Release: MaSTherCell Expands Production by Doubling Its Capacity". Gosselies. 2018-11-30
Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]". 2018-11-29
Forbion Capital Partners. (11/29/18). "Press Release: Forbion Appoints Dr. Carlo Incerti as Operating Partner". Naarden & Munich. 2018-11-29
Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen. 2018-11-29
Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". 2018-11-29
Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology". 2018-11-28
Hookipa Pharma Inc.. (11/28/18). "Press Release: Hookipa and DarwinHealth Enter into a Research Collaboration and License Agreement". New York, NY & Vienna. 2018-11-28
Qiagen N.V.. (11/28/18). "Press Release: Qiagen Extends Comprehensive Offering for Cervical Cancer Screening with European Launch of QIAscreen HPV PCR Test". Hilden. 2018-11-28
Carbios S.A.. (11/28/18). "Press Release: Carbios and Kem One Sign a Letter of Intent to Implement a PET Biorecycling Demonstration Plant Operated by Carbios in the French Chemical Valley". Clermont-Ferrand. 2018-11-28
Galapagos N.V.. (11/27/18). "Press Release: Galapagos Receives Fast Track Designation from FDA for GLPG1972/S201086 in Osteoarthritis". Mechelen. 2018-11-27
Jecure Therapeutics Inc.. (11/27/18). "Press Release: Genentech Acquires Jecure Therapeutics". San Diego, CA. 2018-11-27
Sygnature Discovery Ltd.. (11/27/18). "Press Release: Sygnature Discovery Establishes US Office in Cambridge, MA". Nottingham & Cambridge, MA. 2018-11-27
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". 2018-11-27
Genomics Medicine Ireland Ltd.. (11/27/18). "Press Release: $400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences". 2018-11-27
Inkef Capital. (11/27/18). "Press Release: Inkef Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund". Amsterdam. 2018-11-27
Arsanis, Inc.. (11/27/18). "Press Release: Arsanis and X4 Pharmaceuticals Agree to Merger". Cambridge, MA, Waltham, MA & Vienna. 2018-11-27
German Accelerator Life Sciences. (11/27/18). "Press Release: German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round". Freiburg & Cambridge, MA. 2018-11-27
GlaxoSmithKline plc. (11/26/18). "Press Release: Juluca (dolutegravir/rilpivirine), the First Single Pill, 2-drug Regimen, for the Maintenance Treatment of HIV, Granted Marketing Approval by Japan Ministry of Health, Labour and Welfare". London. 2018-11-26
Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug. 2018-11-26
Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London. 2018-11-26
MorphoSys AG. (11/26/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis". Planegg. 2018-11-26
Bayer Corporation. (11/26/18). "Press Release: FDA Approves Vitrakvi (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion". Whippany, NJ & Stamford, CT. 2018-11-26
Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto. 2018-11-26
Eurofins Scientific. (11/26/18). "Press Release: Eurofins Further Reduces Its Financing Costs after Redeeming Its EUR 300m November 2018 Eurobond and Extends Its Organic Growth Objectives beyond 2020". 2018-11-26
Immune Regulation Ltd.. (11/26/18). "Press Release: Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104". Stevenage. 2018-11-26
PerkinElmer, Inc.. (11/26/18). "Press Release: PerkinElmer Receives CE-IVD Mark for Its Vanadis Fully Automated NIPT Platform". Waltham, MA. 2018-11-26
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
Fluidic Analytics Ltd.. (11/26/18). "Press Release: Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases". 2018-11-26
Curetis N.V.. (11/23/18). "Press Release: Curetis Announces Financial Results for the First Nine Months of 2018". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-23
Oxford BioMedica plc. (11/23/18). "Press Release: Oxford BioMedica Announces New Digital Framework Initiative to Streamline the Production of Next-generation Medicines with Cash Injection from Innovate UK". Oxford. 2018-11-23
Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia, 2018-11-23
Merck KGaA. (11/23/18). "Press Release: Merck Appoints Jasper Bos as Managing Director of M Ventures". Darmstadt. 2018-11-23
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate Announces Change of Name to Immune Regulation, Strengthening of the Board and Successful Fundraise". 2018-11-22
Astellas Pharma Inc.. (11/22/18). "Press Release: Astellas Executes License Agreement with an Option to Acquire JVS-100 Gene Therapy Program from Juventas". Tokyo & Cleveland, OH. 2018-11-22
F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. 2018-11-22
GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London. 2018-11-22
Novadiscovery. (11/22/18). "Press Release: Novadiscovery Welcomes Two New Members to Its Team to Strengthen Its Combined Expertise in Artificial Intelligence and Clinical Medicine". Lyon. 2018-11-22
BRAIN AG. (11/21/18). "Press Release: Manfred Bender Set to Join BRAIN AG’s Management Board as Chief Financial Officer (CFO)". Zwingenberg. 2018-11-21
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. 2018-11-21
Evotec AG. (11/21/18). "Press Release: Evotec and Immuneering to Collaborate on Artifical Intelligence (“AI”) Driven Ligand Identification for Rare Hereditary Metabolic Diseases". Hamburg & Cambridge, MA. 2018-11-21
1 2 3 ... 167 168 169  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

» top